ETF Components for FPXI - First Trust International IPO ETF


Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

Holdings

Symbol Grade Price % Change Allocation
ARM B 0.13 7.00
SPOT A -0.16 5.28
MNDY A 1.93 5.18
NU C -4.97 4.46
GEN A -2.89 3.32
SN C -3.35 2.82
NVO F -0.01 2.37
ONON D -1.94 1.90
CPNG B -1.51 1.60
RBA A 0.42 1.54
TCOM A 1.23 1.50
TEVA A 0.05 1.03
VIST B -1.00 0.29

Recent News for First Trust International IPO ETF & its Holdings

Date Stock Title
Nov 1 SPOT Spotify (SPOT) Stock Falls Amid Market Uptick: What Investors Need to Know
Nov 1 NVO Election Day, Fed decision, earnings: What to Watch Next Week
Nov 1 TEVA Teva long-acting olanzapine shows improvements in schizophrenia patients
Nov 1 TEVA Teva Presents New Tardive Dyskinesia Data at Psych Congress 2024 from the IMPACT-TD Registry, Revealing Differences in Patient Experience Based on Underlying Psychiatric Condition
Nov 1 TEVA Teva Presents Latest Schizophrenia Treatment Research, Including Phase 3 SOLARIS Trial Results Demonstrating Improvements in Social Functioning and Quality of Life in Adults Receiving TEV-'749 (olanzapine) a Subcutaneous Long-Acting Injectable as well ...
Nov 1 NVO Why iShares’ Europe ETF (IEUR) May Be Attractive for U.S. Investors
Nov 1 ARM AI Chip Leader, Ferrari Headline Next Earnings Wave, But These Risks Loom
Nov 1 NVO Madrigal Catapults After Novo's Wegovy Proves It's No 'Silver Bullet' In MASH
Nov 1 GEN How Gen Digital uses AI to detect scams as election heightens risk: CEO
Nov 1 ARM Stocks to watch next week: Berkshire Hathaway, Super Micro, Novo Nordisk, Vistry and M&S
Nov 1 SN SharkNinja Third Quarter 2024 Earnings: Beats Expectations
Nov 1 ARM Bernstein Downgrades Arm Holdings plc (ARM) to ‘Underperform’ Amid Concerns Beyond AI Revenue Prospects
Nov 1 NVO Novo Nordisk's Semaglutide Trial Shows 'Superior Improvement' in Liver Fibrosis, MASH
Nov 1 NVO Novo Nordisk Says Wegovy Improved Patients’ Liver Disease
Nov 1 SN SharkNinja, Inc. (SN) Loses -15.44% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Nov 1 TEVA Countdown to Teva Pharmaceutical Industries (TEVA) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Nov 1 NVO Popular Weight Loss Drug Wegovy Shows Encouraging Results in Liver Fibrosis Trial
Nov 1 NVO Novo Nordisk posts Phase 3 win for obesity drug in MASH
Nov 1 NVO Novo Nordisk A/S: Semaglutide 2.4 mg demonstrates superior improvement in both liver fibrosis and MASH resolution in the ESSENCE trial
Nov 1 GEN US added far fewer jobs than expected in October, Amazon & Intel lead tech stocks: Yahoo Finance
The investment seeks investment results that correspond generally to the price andyield (before the fund's fees and expenses) of an index called the IPOXInternational Index. The fund will normally invest at least 90% of its net assets (plus the amount ofany borrowings for investment purposes) in common stocks and/or depositaryreceipts that comprise the index. The index is a market-cap weightedportfolio measuring the performance of the top 50 non-U.S. companies, includingcompanies domiciled in emerging markets, ranked quarterly by marketcapitalization in the IPOX(R) Global Composite Index (the "Base Index"). The fund is non-diversified.
Exchange Traded Fund ETF Index Fund Active Management
Back to the Main FPXI Page...